Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
January 5, 2022	4	Statement of changes in beneficial ownership of securities	0001562180-22-000236.pdf 0001562180-22-000236.rtf 0001562180-22-000236.xls View HTML
January 24, 2022	8-K	Report of unscheduled material events or corporate event	0001193125-22-016101.pdf 0001193125-22-016101.rtf 0001193125-22-016101.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
January 28, 2022	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-22-021580.pdf 0001193125-22-021580.rtf 0001193125-22-021580.xls View HTML
February 7, 2022	SC 13G/A	An amendment to the SC 13G filing	0000834237-22-007946.pdf 0000834237-22-007946.rtf View HTML
February 9, 2022	SC 13G/A	An amendment to the SC 13G filing	0001104659-22-016399.pdf 0001104659-22-016399.rtf View HTML
February 10, 2022	SC 13G/A	An amendment to the SC 13G filing	0000093751-22-000122.pdf 0000093751-22-000122.rtf View HTML
February 18, 2022	4/A	Amendment to a previously filed 4	0001562180-22-001654.pdf 0001562180-22-001654.rtf 0001562180-22-001654.xls View HTML
February 22, 2022	8-K	Report of unscheduled material events or corporate event	0001193125-22-047773.pdf 0001193125-22-047773.rtf 0001193125-22-047773.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 1, 2022	8-K	Report of unscheduled material events or corporate event	0001193125-22-061300.pdf 0001193125-22-061300.rtf 0001193125-22-061300.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 1, 2022	POSASR	POSASR	0001193125-22-061326.pdf 0001193125-22-061326.rtf 0001193125-22-061326.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax